The United States Pharmerging Market is further driven by robust biotechnology development, clinical research activities, strategic industry partnerships, and continued investment in novel treatments and healthcare innovation. Growing demand for specialty pharmaceuticals, biologics, precision medicine, and advanced therapies is creating new opportunities for pharmaceutical companies and...